![Viktor Roschke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Viktor Roschke
Technik-/Wissenschafts-/F&E-Leiter bei
D&D PHARMATECH INC.
Vermögen: 30 Mio $ am 31.05.2026
Profil
Viktor Roschke is the founder of Neuraly, Inc. since 2016, holding the title of Director & Chief Scientific Officer.
Current jobs include Secretary & Director at Theraly Fibrosis, Inc. and Chief Scientific Officer at D&D Pharmatech Co., Ltd. Former jobs include Executive Director-Cell Biology at Human Genome Sciences, Inc. from 2005, VP-Biopharmaceutical Research & Assay Development at Zyngenia, Inc., and Chief Operating Officer at Teva Biopharmaceuticals USA, Inc. Education includes a doctorate from Novosibirsk State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 04.06.2025 | 482.036 ( 1,1 % ) | 30 Mio $ | 31.05.2026 |
Aktive Positionen von Viktor Roschke
| Unternehmen | Position | Beginn |
|---|---|---|
| D&D PHARMATECH INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Theraly Fibrosis, Inc.
 Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Direktor/Vorstandsmitglied | - |
Neuraly, Inc.
 Neuraly, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in physical and biological research | Gründer | 01.01.2016 |
Ehemalige bekannte Positionen von Viktor Roschke
| Unternehmen | Position | Ende |
|---|---|---|
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Corporate Officer/Principal | 01.01.2005 |
Teva Biopharmaceuticals USA, Inc.
 Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Develops and commercializes biological products | Geschäftsführer | - |
Zyngenia, Inc.
 Zyngenia, Inc. Drugstore ChainsRetail Trade Develops new class of biotherapeutics | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Viktor Roschke
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
40
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Zyngenia, Inc.
Zyngenia, Inc. Drugstore ChainsRetail Trade Develops new class of biotherapeutics | Retail Trade |
Novosibirsk State University
 Novosibirsk State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Teva Biopharmaceuticals USA, Inc.
Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Develops and commercializes biological products | Health Technology |
Neuraly, Inc.
Neuraly, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in physical and biological research | Commercial Services |
Theraly Fibrosis, Inc.
Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
D&D Pharma Tech Co., Ltd.
 D&D Pharma Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
